Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Recursion Pharmaceuticals Inc Cl A (RXRX)

Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,783,363
  • Shares Outstanding, K 234,653
  • Annual Sales, $ 44,580 K
  • Annual Income, $ -328,070 K
  • 60-Month Beta 0.76
  • Price/Sales 38.69
  • Price/Cash Flow N/A
  • Price/Book 3.74
Trade RXRX with:

Options Overview Details

View History
  • Implied Volatility 85.92% ( -3.74%)
  • Historical Volatility 55.06%
  • IV Percentile 24%
  • IV Rank 35.84%
  • IV High 160.69% on 07/12/23
  • IV Low 44.15% on 10/03/23
  • Put/Call Vol Ratio 0.07
  • Today's Volume 1,301
  • Volume Avg (30-Day) 3,358
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 73,395
  • Open Int (30-Day) 78,608

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.43
  • Number of Estimates 2
  • High Estimate -0.41
  • Low Estimate -0.45
  • Prior Year -0.34
  • Growth Rate Est. (year over year) -26.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.14 +10.39%
on 04/19/24
10.91 -27.81%
on 03/25/24
-2.61 (-24.92%)
since 03/22/24
3-Month
7.14 +10.39%
on 04/19/24
15.74 -49.96%
on 02/27/24
-2.76 (-25.97%)
since 01/23/24
52-Week
4.54 +73.49%
on 05/02/23
16.75 -52.96%
on 07/19/23
+2.16 (+37.70%)
since 04/21/23

Most Recent Stories

More News
Where Will Recursion Pharmaceuticals Be in 5 Years?

A lot is riding on whether its platform is valuable, or vaporware.

RXRX : 7.85 (+3.29%)
6 Under-the-Radar AI Stocks That Analysts Expect to Rally

Morgan Stanley is betting on these stocks to benefit from the AI megatrend.

NVDA : 817.40 (+2.79%)
MSFT : 406.72 (+1.44%)
AMZN : 178.64 (+0.80%)
MS : 93.64 (+1.68%)
RXRX : 7.85 (+3.29%)
SDGR : 25.01 (+2.12%)
DH : 7.30 (-0.41%)
RBLX : 36.81 (+5.29%)
SRAD : 9.77 (+0.83%)
SPGI : 412.93 (-0.96%)
Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.

Recursion is playing the long game with its AI-focused approach to drug discovery and development.

RHHBY : 31.3000 (+1.26%)
RXRX : 7.85 (+3.29%)
The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation

They might not be profitable yet, but they're swinging for the fences.

DNA : 0.8583 (+1.84%)
RXRX : 7.85 (+3.29%)
Is This Under-the-Radar Artificial Intelligence (AI) Stock a Buy?

This stock's upside is huge, but so is its downside.

RXRX : 7.85 (+3.29%)
1 AI Growth Stock With 54% Upside Potential

Shares of Recursion Pharmaceuticals offer solid upside potential, given the company's trailblazing approach to drug discovery leveraging AI. Here’s a closer look at the biotech stock that has garnered...

GS : 423.67 (+1.51%)
RXRX : 7.85 (+3.29%)
NVDA : 817.40 (+2.79%)
ARKK : 43.80 (+2.82%)
$SPX : 5,068.16 (+1.15%)
BAYZF : 29.1900 (+0.40%)
Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst

The company just made a provocative move in one of its collaborations.

RXRX : 7.85 (+3.29%)
Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today

The company had attracted much interest due to its heavy use of artificial intelligence, but its latest fundamentals disappointed many.

RXRX : 7.85 (+3.29%)
These 2 Healthcare Stocks Are in Nvidia's Portfolio. Should They Be in Yours?

These companies are focused on next-gen technologies that could help transform the healthcare industry.

NVDA : 817.40 (+2.79%)
NNOX : 9.41 (+4.32%)
RXRX : 7.85 (+3.29%)
Nvidia Just Invested in These 5 Artificial Intelligence (AI) Stocks. Here's the Best of the Bunch.

See which AI stocks the world's hottest AI chipmaker especially likes.

NVDA : 817.40 (+2.79%)
ARM : 96.04 (+3.15%)
NNOX : 9.41 (+4.32%)
RXRX : 7.85 (+3.29%)
SOUN : 4.22 (+11.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.

See More

Key Turning Points

3rd Resistance Point 8.44
2nd Resistance Point 8.12
1st Resistance Point 7.86
Last Price 7.85
1st Support Level 7.27
2nd Support Level 6.95
3rd Support Level 6.69

See More

52-Week High 16.75
Fibonacci 61.8% 12.08
Fibonacci 50% 10.64
Fibonacci 38.2% 9.20
Last Price 7.85
52-Week Low 4.54

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar